See more : Raen S.A. (RAE.WA) Income Statement Analysis – Financial Results
Complete financial analysis of Olink Holding AB (publ) (OLK) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Olink Holding AB (publ), a leading company in the Medical – Diagnostics & Research industry within the Healthcare sector.
- Loyal Lithium Limited (LLI.AX) Income Statement Analysis – Financial Results
- Ströer SE & Co. KGaA (SAX.DE) Income Statement Analysis – Financial Results
- e-therapeutics plc (ETXPF) Income Statement Analysis – Financial Results
- Healthy Coffee International, Inc. (HCEI) Income Statement Analysis – Financial Results
- Jiangsu Wuyang Parking Industry Group Co.,Ltd. (300420.SZ) Income Statement Analysis – Financial Results
Olink Holding AB (publ) (OLK)
About Olink Holding AB (publ)
Olink Holding AB (publ) provides various products and services for the academic, government, biopharmaceutical, biotechnology, and other institutions that focuses on life science research. Its products include Olink Explore for cardiovascular and metabolic, oncology, neurology, or inflammation diseases; Olink Target product line; and Olink Focus product line that consists of custom developed solutions for customers that has identified various proteins of interest or a protein signature to focus on. The company's products also comprise Olink Signature Q100, a qPCR readout platform; Olink Analysis services comprising study design and consultation, sample preparation and assay execution, and data processing and QC; and bioinformatics services. In addition, it provides Olink normalized protein expression (NPX) Manager, a purpose-built software that enable users to import data, validate data quality, and normalize for subsequent statistical analysis; and Olink Insight, a cloud platform for data visualization and statistical analysis of NPX data. Olink Holding AB (publ) sells its products and services through its own direct sales force in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company was formerly known as Knilo HoldCo AB and changed its name to Olink Holding AB (publ) in January 2021. The company was founded in 2004 and is headquartered in Uppsala, Sweden. Olink Holding AB (publ) is a subsidiary of Summa Equity Holding AB.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 169.91M | 139.85M | 94.97M | 54.07M | 41.69M |
| Cost of Revenue | 71.04M | 45.35M | 36.76M | 17.46M | 13.02M |
| Gross Profit | 98.87M | 94.50M | 58.21M | 36.61M | 28.68M |
| Gross Profit Ratio | 58.19% | 67.57% | 61.29% | 67.71% | 68.78% |
| Research & Development | 30.57M | 26.35M | 22.14M | 9.63M | 4.85M |
| General & Administrative | 105.79M | 54.27M | 47.50M | 20.10M | 26.61M |
| Selling & Marketing | 12.24M | 44.67M | 33.67M | 12.72M | 8.25M |
| SG&A | 118.25M | 98.95M | 81.16M | 32.82M | 34.86M |
| Other Expenses | 0.00 | -191.00K | -443.00K | -475.00K | -363.00K |
| Operating Expenses | 148.81M | 125.10M | 102.86M | 41.98M | 39.34M |
| Cost & Expenses | 219.85M | 170.45M | 139.62M | 59.44M | 52.36M |
| Interest Income | 6.51M | 1.16M | 98.00K | 6.63M | 7.00K |
| Interest Expense | 858.00K | 531.00K | 2.05M | 6.63M | 6.60M |
| Depreciation & Amortization | 19.03M | 18.99M | 14.08M | 12.54M | 7.87M |
| EBITDA | -30.91M | -11.61M | -30.57M | 6.46M | -2.79M |
| EBITDA Ratio | -18.19% | -8.30% | -32.19% | 11.94% | -6.70% |
| Operating Income | -49.94M | -30.60M | -44.65M | -6.08M | -10.66M |
| Operating Income Ratio | -29.39% | -21.88% | -47.02% | -11.25% | -25.58% |
| Total Other Income/Expenses | 10.30M | 15.20M | -1.89M | -1.89M | -140.99K |
| Income Before Tax | -39.98M | -15.41M | -46.55M | -7.26M | -18.53M |
| Income Before Tax Ratio | -23.53% | -11.02% | -49.01% | -13.43% | -44.44% |
| Income Tax Expense | -8.32M | -2.56M | -8.21M | -479.00K | -652.00K |
| Net Income | -31.66M | -12.85M | -38.34M | -6.78M | -17.88M |
| Net Income Ratio | -18.63% | -9.19% | -40.37% | -12.54% | -42.88% |
| EPS | -0.26 | -0.11 | -0.39 | -0.03 | -0.07 |
| EPS Diluted | -0.26 | -0.11 | -0.39 | -0.03 | -0.07 |
| Weighted Avg Shares Out | 124.00M | 119.08M | 99.26M | 257.23M | 257.23M |
| Weighted Avg Shares Out (Dil) | 124.00M | 119.08M | 99.26M | 257.23M | 257.23M |
Novogene Asia Pacific Middle East and Africa adopts Olink® Explore HT technology to accelerate multi-omics research with next generation proteomics
OLINK HOLDING INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Olink Holding AB - OLK
Should You Still Buy the Nasdaq's Best-Performing October Stocks?
Analysts Estimate Olink Holding AB (publ) Sponsored ADR (OLK) to Report a Decline in Earnings: What to Look Out for
Thermo Fisher Scientific Commences Tender Offer for All Outstanding Common Shares and ADSs of Olink
OLINK HOLDING INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Olink Holding AB - OLK
Strength Seen in Olink Holding AB (publ) Sponsored ADR (OLK): Can Its 66.0% Jump Turn into More Strength?
Olink Holding stock soars on acquisition by Thermo Fisher Scientific
Why Olink Stock Is Skyrocketing Today
OLK Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Olink Holding AB (publ) Is Fair to Shareholders
Source: https://incomestatements.info
Category: Stock Reports